Compounds > 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt
Page last updated: 2024-08-20

1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt and Central Nervous System Disease

1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt has been researched along with Central Nervous System Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nordby, EJ; Schofield, SR; Wright, PH1

Reviews

1 review(s) available for 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt and Central Nervous System Disease

ArticleYear
Safety of chemonucleolysis. Adverse effects reported in the United States, 1982-1991.
    Clinical orthopaedics and related research, 1993, Issue:293

    Topics: Adult; Aged; Anaphylaxis; Bacterial Infections; Central Nervous System Diseases; Chymopapain; Female; Hemorrhage; Humans; Intervertebral Disc Chemolysis; Lumbar Vertebrae; Male; Middle Aged; Paralysis; United States

1993